ACTIVE

ChemoSensoryX Biosciences SA

Financial year 2025 · Closed on 31/12/2025

Net result-1,4 M €-26 940,9 %over 1 year
Gross margin-597,5 k €-12 095,6 %over 1 year
Equity-441,9 k €-164,0 %over 1 year

Identity

Source · BCE/KBO

ChemoSensoryX Biosciences SA is a Public limited company incorporated in 2004. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Ottignies-Louvain-la-Neuve.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0867.817.428
Incorporation
13/10/2004
Legal form
Public limited company
Registered office
Avenue Jean Monnet 1
1348 Ottignies-Louvain-la-Neuve · WallonieSee on map
Contributed capital
975 871,68 €
Latest accounts
31/12/2025
Signals
Healthy social debts

Financials

Source · NBB, 20 filings

Trend over 16 financial years

20252024202320222018
Income statement
Gross margin-597,5 k €-4,9 k €-2,6 k €–-68,9 €
EBITDA-1,1 M €-4,9 k €-3 k €-347,5 €-685,6 €
Operating result-1,4 M €-4,9 k €-3 k €-347,5 €-685,6 €
Net result-1,4 M €-5 k €-3 k €-466,2 €-685 €
Balance sheet
Equity-441,9 k €690,5 k €8,7 k €11,8 k €13,7 k €
Total assets1,5 M €690,7 k €8,7 k €12,1 k €14,3 k €
Cash521,4 k €690,7 k €3,6 k €12,1 k €14,2 k €
Debts2 M €211,8 €0 €347,5 €541,6 €

Board of directors

Source · NBB, accounts to 31/12/2025

7 active · 28 ended

Active mandates

Bernard Boulin

Director · since 19 décembre 2025 · until 30 mai 2031

Active
Guillaume Tardif

Director · since 19 décembre 2025 · until 30 mai 2031

Active
ACADEMIC MEDICAL INTERDISCIPLINARY RESEARCH FOUNDATION - RECHERCHE ACADEMIQUE MEDICALE INTERDISCIPLINAIRE FOUNDATION

Director · since 31 décembre 2024 · until 19 décembre 2025 · 0470.524.630

Represented by Joelle Dumont

Active
Association Recherche biomédicale et Diagnostic

Director · since 31 décembre 2024 · until 19 décembre 2025 · 0416.287.871

Represented by Gilbert Vassart

Active
Bernard Delwart

Director · since 31 décembre 2024 · until 19 décembre 2025

Active
CONTHEGAS CONSULTING

Director · since 31 décembre 2024 · until 19 décembre 2025 · 0536.192.442

Represented by Jean-François Pollet

Active
COVORIM

Director · since 31 décembre 2024 · until 19 décembre 2025 · 0866.942.943

Represented by Benedikt Van Der Vorst

Active

Ended mandates

ACADEMIC MEDICAL INTERDISCIPLINARY RESEARCH FOUNDATION - RECHERCHE ACADEMIQUE MEDICALE INTERDISCIPLINAIRE FOUNDATION

Director · since 31 décembre 2024 · 0470.524.630

Represented by Joëlle DUMONT

Ended
ACADEMIC MEDICAL INTERDISCIPLINARY RESEARCH FOUNDATION - RECHERCHE ACADEMIQUE MEDICALE INTERDISCIPLINAIRE FOUNDATION

Director · since 31 décembre 2024 · 0470.524.630

Represented by Joëlle Dumont

Ended
Association Recherche biomédicale et Diagnostic

Director · since 31 décembre 2024 · 0416.287.871

Represented by Gilbert Vassert

Ended
Association Recherche biomédicale et Diagnostic

Director · since 31 décembre 2024 · 0416.287.871

Represented by Gilbert VASSART

Ended

Other companies at this address

Avenue Jean Monnet 1 1348 Ottignies-Louvain-la-Neuve
CompanyCBE no.
AIR VISION● Active
0466.468.644
1009.117.031
0763.364.660
0460.900.052
Charmoz Invest● Active
1025.992.754
CHEMIUM● Active
0640.872.565
DNAlytics● Active
0844.973.235
FEMAG● Active
0566.972.126
GO-PME● Active
0717.854.636
0469.529.092
Inteliphage● Active
0692.975.522
LAPORTE EURO● Active
0767.819.732
1036.995.128
MINAGRO● Active
0739.988.353
0790.626.214
SiPulse● Active
1040.681.722
SUNSWITCH● Bankrupt
0890.449.112
Venturi Holding● Active
1029.462.879

Full financial information

Source · NBB
202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/06/202201/06/202101/06/202001/06/2019
Closing of the financial year31/12/202531/12/202431/12/202331/05/202231/05/202131/05/2020
Length of the financial year12 months12 months19 months12 months12 months12 months
Filing date29/06/202603/07/202510/07/202415/12/202207/12/202121/01/2021
General meeting29/05/202630/06/202518/06/202425/11/202226/11/202127/11/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202529/05/202629/06/2026FrenchPDF
Micro model31/12/202430/06/202503/07/2025FrenchPDF
Micro model31/12/202318/06/202410/07/2024DutchPDF
Micro model31/05/202225/11/202215/12/2022DutchPDF
Micro model31/05/202126/11/202107/12/2021DutchPDF
Micro model31/05/202027/11/202021/01/2021DutchPDF
Micro model31/05/201929/11/201905/12/2019DutchPDF
Abridged model31/05/201830/11/201806/12/2018DutchPDF
Abridged model31/05/201727/11/201727/12/2017DutchPDF
Abridged model31/05/201627/11/201615/02/2017DutchPDF
Abridged model31/05/201527/11/201509/12/2015DutchPDF
Abridged model31/05/201428/11/201412/12/2014DutchPDF
Abridged model31/05/201329/11/201313/01/2014DutchPDF
Abridged model31/05/201230/11/201219/12/2012DutchPDF
Abridged model31/05/201125/11/201123/12/2011DutchPDF
Abridged model31/05/201026/11/201030/12/2010DutchPDF
Abridged model31/05/200927/11/200914/12/2009DutchPDF
Abridged model31/05/200812/12/200829/12/2008DutchPDF
Abridged model31/05/200721/12/200728/12/2007FrenchPDF
Abridged model31/05/200630/11/200602/01/2007FrenchPDF

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

7 active · 28 ended

Active mandates

Bernard Boulin

Director · since 19 décembre 2025 · until 30 mai 2031

Active
Guillaume Tardif

Director · since 19 décembre 2025 · until 30 mai 2031

Active
ACADEMIC MEDICAL INTERDISCIPLINARY RESEARCH FOUNDATION - RECHERCHE ACADEMIQUE MEDICALE INTERDISCIPLINAIRE FOUNDATION

Director · since 31 décembre 2024 · until 19 décembre 2025 · 0470.524.630

Represented by Joelle Dumont

Active
Association Recherche biomédicale et Diagnostic

Director · since 31 décembre 2024 · until 19 décembre 2025 · 0416.287.871

Represented by Gilbert Vassart

Active
Bernard Delwart

Director · since 31 décembre 2024 · until 19 décembre 2025

Active
CONTHEGAS CONSULTING

Director · since 31 décembre 2024 · until 19 décembre 2025 · 0536.192.442

Represented by Jean-François Pollet

Active
COVORIM

Director · since 31 décembre 2024 · until 19 décembre 2025 · 0866.942.943

Represented by Benedikt Van Der Vorst

Active

Ended mandates

ACADEMIC MEDICAL INTERDISCIPLINARY RESEARCH FOUNDATION - RECHERCHE ACADEMIQUE MEDICALE INTERDISCIPLINAIRE FOUNDATION

Director · since 31 décembre 2024 · 0470.524.630

Represented by Joëlle DUMONT

Ended
ACADEMIC MEDICAL INTERDISCIPLINARY RESEARCH FOUNDATION - RECHERCHE ACADEMIQUE MEDICALE INTERDISCIPLINAIRE FOUNDATION

Director · since 31 décembre 2024 · 0470.524.630

Represented by Joëlle Dumont

Ended
Association Recherche biomédicale et Diagnostic

Director · since 31 décembre 2024 · 0416.287.871

Represented by Gilbert Vassert

Ended
Association Recherche biomédicale et Diagnostic

Director · since 31 décembre 2024 · 0416.287.871

Represented by Gilbert VASSART

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates05/02/2026
    CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
    PDF
  • Registered office18/09/2025
    SIEGE SOCIAL
    PDF
  • Capital / shares05/09/2025
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS
    PDF
  • Mandates17/01/2025
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - DENOMINATION - SIEGE SOCIAL - OBJET - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE
    PDF
  • Mandates28/02/2023
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE - ANNEE COMPTABLE
    PDF
  • Mandates22/03/2018
    MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office18/11/2015
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Mandates06/01/2012
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-1,4 M €↓
  2. 2025
    Name changeChemoSensoryX
  3. 2024
    Annual accounts 2024-5 k €↓
  4. 2024
    Name changeCHEMOSENSORYX BIOSCIENCES
  5. 2023
    Annual accounts 2023-3 k €↓
  6. 2022
    Annual accounts 2022-466,2 €↑
  7. 2018
    Annual accounts 2018-685 €↑
  8. 2017
    Annual accounts 2017-3 k €↑
  9. 2016
    Annual accounts 2016-3,2 k €↓
  10. 2015
    Annual accounts 2015-557,6 €↓
  11. 2014
    Annual accounts 20142 k €↑
  12. 2013
    Annual accounts 2013-7,1 k €↑
  13. 2012
    Annual accounts 2012-21,7 k €↓
  14. 2011
    Annual accounts 2011-9,2 k €↓
  15. 2010
    Annual accounts 2010-2,7 k €↓
  16. 2009
    Annual accounts 2009-936 €↑
  17. 2008
    Annual accounts 2008-7,4 k €↓
  18. 2007
    Annual accounts 2007315,1 k €
  19. 2007
    Name changeDIXMUDE DEVELOPMENT
  20. 13/10/2004
    IncorporationPublic limited company